Citation Impact

Citing Papers

Does the Evidence Support the Use of Mycophenolate Mofetil Therapeutic Drug Monitoring in Clinical Practice? A Systematic Review
2008
Glutathione Peroxidase-1 Overexpression Prevents Ceramide Production and Partially Inhibits Apoptosis in Doxorubicin-Treated Human Breast Carcinoma Cells
2001
ROS stress in cancer cells and therapeutic implications
2004 Standout
Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression
2017 Standout
Mechanism of apoptosis induced by apigenin in hepg2 human hepatoma cells: involvement of reactive oxygen species generated by NADPH oxidase
2007
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
2008 Standout
Complementary and alternative medicine: use and disclosure in radiation oncology community practice
2010 Standout
Caspase-8 dependent trail-induced apoptosis in cancer cell lines is inhibited by vitamin C and catalase
2006
The Role of Therapeutic Drug Monitoring in Individualizing Immunosuppressive Drug Therapy: Recent Developments
2006
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Role of NADPH oxidase-mediated generation of reactive oxygen species in the mechanism of apoptosis induced by phenolic acids in HepG2 human hepatoma cells
2005
Role of hydrogen peroxide and oxidative stress in healing responses
2002
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Elevated superoxide production by active H-ras enhances human lung WI-38VA-13 cell proliferation, migration and resistance to TNF-α
2001
Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine
2004
Enteric Coated Mycophenolate Sodium is Therapeutically Equivalent to Mycophenolate Mofetil in de novoRenal Transplant Patients
2004
Therapeutic Drug Monitoring of Mycophenolate Mofetil in Transplantation
2006
Enteric-Coated Mycophenolate Sodium can be Safely Administered in Maintenance Renal Transplant Patients: Results of a 1-Year Study
2004
Imaging Dynamic Redox Changes in Mammalian Cells with Green Fluorescent Protein Indicators
2004 StandoutNobel
Neurological complications after orthotopic liver transplantation
2007
Differential regulation of cyclooxygenase‐2 and inducible nitric oxide synthase by 4‐hydroxynonenal in human osteoarthritic chondrocytes through ATF‐2/CREB‐1 transactivation and concomitant inhibition of NF‐κB signaling cascade
2006
ROS signalling in the biology of cancer
2017 Standout
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
Oxidative Stress: Harms and Benefits for Human Health
2017 Standout
Factors affecting operational tolerance after pediatric living-donor liver transplantation: impact of early post-transplant events and HLA match*
2011 StandoutNobel
Oxidant Mechanisms in Renal Injury and Disease
2016
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Customized Mycophenolate Dosing Based on Measuring Inosine-Monophosphate Dehydrogenase Activity Significantly Improves Patients' Outcomes After Renal Transplantation
2010
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Antioxidant ameliorates cisplatin-induced renal tubular cell death through inhibition of death receptor-mediated pathways
2003
Salidroside Attenuates Ventilation Induced Lung Injury via SIRT1-Dependent Inhibition of NLRP3 Inflammasome.
2017 Standout

Works of Pia Hambach being referenced

Pharmacodynamic monitoring of mycophenolate mofetil in stable renal allograft recipients
2002
Pharmacokinetic and Pharmacodynamic Comparison of Enteric-Coated Mycophenolate Sodium and Mycophenolate Mofetil in Maintenance Renal Transplant Patients
2007
TNF-α AND IL-1α INDUCE APOPTOSIS IN SUBCONFLUENT RAT MESANGIAL CELLS. EVIDENCE FOR THE INVOLVEMENT OF HYDROGEN PEROXIDE AND LIPID PEROXIDATION AS SECOND MESSENGERS
2000
Effect of mycophenolate mofetil on IMP dehydrogenase after the first dose and after long-term treatment in renal transplant recipients
2003
Pre-Transplant Inosine Monophosphate Dehydrogenase Activity is Associated with Clinical Outcome After Renal Transplantation
2004
Pharmacokinetics and pharmacodynamics of mycophenolate mofetil under oral and intravenous therapy
2002
PHARMACOKINETIC AND PHARMACODYNAMIC COMPARISON OF MYCOPHENOLATE MOFETIL (MMF) AND ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN MAINTENANCE RENAL TRANSPLANT PATIENTS WITH TACROLIMUS AS BASIC IMMUNOSUPPRESSION
2004
Rankless by CCL
2026